Regulatory actions for July 16, 2026
AI Briefing
- • Aspen receives FDA approval for its treatment of migraine headaches.
- • Axsome receives FDA approval for its treatment of major depressive disorder.
- • Celcuity receives FDA Breakthrough Therapy designation for its cancer treatment.
Context
Regulatory actions are taking place on July 16, 2026. Companies involved include Aspen, Axsome, Celcuity, Meridian, Orasis, and Roche. These actions pertain to biopharma and med tech.
These regulatory decisions and designations involve global submissions and approvals. They also include other regulatory matters for the mentioned companies.
Advertisement